Abingdon Health plc
("Abingdon Health" or "the Company")
Change of Nominated Adviser and Broker
The Company announces its Nominated Adviser and Broker has changed to Zeus Capital Limited with immediate effect.
This change follows completion of the acquisition by Zeus Capital Limited of the WH Ireland Capital Markets Division (from WH Ireland Limited), announced earlier today.
For further information please contact:
Enquiries
|
Abingdon Health plc |
|
|
Chris Yates, Chief Executive Officer |
|
|
Chris Hand, Non-Executive Chairman
|
|
|
Zeus Capital (Sole Broker and Nominated Adviser) |
Tel: +44 (0) 20 7220 1666 |
|
Chris Fielding / Isaac Hooper (Corporate Finance) |
|
|
Fraser Marshall (Corporate Broking) |
|
The person responsible for arranging the release of this announcement on behalf of the Company is Chris Yates, Chief Executive Officer of the Company.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
